May 11, 2015
MTPC President Masayuki Mitsuka Mitsubishi Tanabe Pharma Corporation (MTPC) projects sales growth for its flagship anti-human TNFα monoclonal antibody Remicade (infliximab) in FY2015 despite its competition with biosimilars, MTPC executives said at the company’s earnings conference on May 8. For...read more